Global Down Syndrome

Issue 3 of 4 2017

Issue link: https://viewer.e-digitaledition.com/i/866792

Contents of this Issue

Navigation

Page 10 of 31

SCIENCE SNPs IMPACT OF ADENOTONSILLECTOMY ON OBSTRUCTIVE SLEEP APNEA The surgical removal of the adenoids and tonsils, or adenotonsillectomy, is a common procedure to treat obstructive sleep apnea (OSA) in Down syndrome. Researchers at the University of California San Diego completed an exhaustive meta-analysis of the literature to determine the ultimate impacts of adenotonsillectomy on OSA in this population. The authors concluded that although adenotonsillectomy has a positive effect on average, it is often noncurative, with up to 75 percent of children still needing breathing support after surgery. Intriguingly, although respiratory function was improved, there were no significant improvements in sleep efficiency on average. The authors recommend continuing with sleep studies after surgery, as many children would still need breathing support or a second surgery. Otolaryngology–Head and Neck Surgery, MAY 2017 THE CIRCADIAN CLOCK IS NOT BROKEN Virtually all living organisms are subject to a circadian rhythm, a cycle in their physiological processes that is roughly 24 hours long and tied to light/dark hours. The impact of disrupting the circadian rhythm is obvious when traveling across time zones, when travelers experience "jet lag." Given the common disruption of sleep patterns in people with Down syndrome, researchers at the University of Arizona set out to determine if circadian rhythms are altered in children with trisomy 21 relative to typical children. Using various measures of sleep patterns and markers of circadian rhythms, they observed that despite strong signs of sleep disturbance, children with Down syndrome do not have an altered circadian rhythm. This reinforces the notion that sleep problems are driven by airway function and the use of melatonin or other strategies used to modulate the circadian clock should be discouraged. Sleep Medicine, MAY 2017 LINKING DYRK1A TO ALZHEIMER'S DISEASE It is established that the increased incidence of Alzheimer's disease in the population with Down syndrome is due to the presence of the APP gene on chromosome 21. However, other genes may also modulate the progression of Alzheimer's. Researchers at the New York State Institute for Basic Research in Developmental Disabilities found that increased levels of DYRK1A, a protein encoded on chromosome 21, produced a change in the balance of tau proteins in the brain of mouse models of Down syndrome. More DYRK1A created an imbalance in the ratio between 3R-tau and 4R-tau, a phenomenon that was previously linked to neurodegenerative conditions. Since tau proteins are known to contribute to Alzheimer's along with the APP protein, these results indicate that reducing DYRK1A activity may normalize the tau imbalance and slow down Alzheimer's progression. Scientific Reports, APRIL 2017 NEW INSIGHT INTO NEONATAL HYPOXEMIA Infants born with lung disorders who do not respond to advanced respiratory therapies usually have low blood oxygen content, or hypoxemia, according to Csaba Galambos, M.D., Ph.D., a pediatric pathologist in the Children's Hospital Colorado Department of Pathology and Laboratory Medicine and Associate Professor of Pathology at the University of Colorado School of Medicine. Dr. Galambos and his colleagues recently identified a group of blood vessels in infants with hypoxemia, including those with Down syndrome, that permit nonoxygenated blood to enter the lungs, therefore contributing to potentially life- threatening hypoxemia. Now, they want to learn how these vessels function. "Our next step is to design animal models that can help identify the regulating mechanisms that open and close these vessels in lung disease, including pulmonary arterial hypertension (PAH)," Dr. Galambos said. "These data will allow us to test interventions that aim to close the vessels, and that will lead to better oxygenation, less severe lung disease, and improved survival of infants with lung disorders, including PAH." GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Issue 3 of 4 2017